Introduction/Overview
Natural products have always been an important source of innovative drug discovery and development, among which polyphenolic compounds have attracted much attention due to their broad biological activity and low toxicity. Veratric acid, also known as 3,4-dimethoxybenzoic acid, is a simple phenolic acid widely found in vegetables, fruits, and medicinal plants. In recent years, it has gradually become a hot topic in pharmacological research. Its CAS number is 93-07-2 and its molecular formula is C9H10O4. Early research focused on the existence and distribution of resveratrol as a secondary metabolite in plants, while pharmacological evidence from the past two decades has systematically revealed the potential value of resveratrol in antioxidant, anti-inflammatory, cardiovascular protection, and skin photodamage protection. Especially in the cardiovascular field, its potential interactions with key targets such as angiotensin-converting enzyme (ACE) and endothelial nitric oxide synthase (NOS3) suggest its potential application prospects in the management of chronic diseases such as hypertension. This article aims to systematically review the chemical properties, natural sources, pharmacological activities, mechanisms of action, pharmacological parameters, and future application prospects of resveratrol, in order to provide comprehensive academic references for the in-depth development and transformation research of this natural product.
Chemical structure and physicochemical properties
Resveratrol acid is a simple derivative of benzoic acid, with its core structure being benzoic acid. A methoxy group (- OCH3) is attached to the 3rd and 4th positions of the benzene ring, hence the systematic name 3,4-dimethoxybenzoic acid. This structure classifies it as a methoxybenzoic acid compound.
Its physicochemical properties directly affect its bioavailability and pharmacological activity. The molecular weight of resveratrol is 182.1750 g/mol, which is relatively small and advantageous for its transmembrane transport. The calculated lipid water partition coefficient (LogP) is about 1.95, indicating that the compound has moderate lipophilicity, can dissolve in lipid environments, and also has a certain degree of water solubility (predicted water solubility is about 2.22 mg/mL), which provides favorable conditions for its distribution and absorption in organisms. Its topological polar surface area (TPSA) is 55.76 Å ², which is relatively low and usually indicates good membrane permeability. Preliminary pharmacological prediction analysis shows that the ability of resveratrol to cross the blood-brain barrier is relatively low, which to some extent limits its direct effects on central nervous system diseases, but may also reduce potential central side effects. In terms of safety warning, existing prediction models suggest that it has no significant hERG potassium channel inhibitory activity (low risk of arrhythmia), and the Ames test prediction value is 0.0, indicating that it may not have a direct genetic toxicity risk, providing preliminary positive signals for its safety assessment.
Plant sources and extraction methods
Resveratrol acid is widely distributed in nature and mainly exists in various edible and traditional medicinal plants. It is one of the important material foundations for its health benefits.
1. Sources of vegetables and fruits It is a component of many common fruits and vegetables, such as chili peppers, carrots, celery, asparagus, as well as certain varieties of apples and grapes. Daily dietary intake is the main pathway through which the human body comes into contact with resveratrol.
2. Source of medicinal plants In traditional medicinal plants, resveratrol is one of the characteristic components of various plants in the lily family and the genus Veratrum, but it should be noted that these plants often contain highly toxic steroid alkaloids. In addition, it is found in other medicinal plants such as Gotu Kola、Angelica dahurica、licorice And some lichens and fungi have also been detected. These plants are often used in traditional medicine for anti-inflammatory, analgesic, and cardiovascular health purposes, and some of their effects may be related to resveratrol.
Regarding the extraction method, depending on the research objectives and scale, the following techniques are mainly used:
* Conventional solvent extraction method The most commonly used method. Usually, methanol, ethanol, ethyl acetate, or water alcohol mixed solvents with different ratios are used for extraction, reflux, or ultrasound assisted extraction of dried and crushed plant materials. This method is simple and easy to implement, suitable for preliminary screening of active sites.
* Modern separation and purification technology In order to obtain high-purity resveratrol for in-depth pharmacological research, column chromatography techniques such as silica gel column chromatography and reverse phase C18 column chromatography are often used to separate the crude extract. High performance liquid chromatography (HPLC) and preparative liquid chromatography (Prep HPLC) are key methods for obtaining chromatographically pure compounds. In recent years, green technologies such as supercritical fluid extraction have also been reported to improve extraction efficiency and selectivity.
* chemical synthesis In addition to natural extraction, resveratrol can also be obtained through chemical synthesis, such as methylation reactions starting from vanillin or protocatechuic acid. The synthesis method can ensure a large and stable supply of standard products, which is an important guarantee for conducting systematic pharmacology and toxicology research.
Pharmacological activity research
Numerous in vitro and in vivo studies have confirmed that resveratrol has diverse pharmacological activities, mainly covering the following aspects:
-
antioxidant activity Resveratrol acid is an effective free radical scavenger. The methoxy and carboxyl groups on its benzene ring can provide hydrogen atoms or electrons, neutralizing reactive oxygen species (ROS) and reactive nitrogen species (RNS) such as DPPH radicals, ABTS radical cations, etc. In cell models, it can enhance the activity of endogenous antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GSH Px), reduce the level of lipid peroxidation product malondialdehyde (MDA), and protect cells from oxidative stress damage. This is the common foundation of its many protective functions.
-
anti-inflammatory activity Resveratrol exhibits significant anti-inflammatory effects. In inflammatory cell models induced by stimuli such as lipopolysaccharide (LPS) or ultraviolet B (UVB), such as macrophages and keratinocytes, resveratrol can effectively inhibit the production of key inflammatory mediators.Of particular note is that in a cell model exposed to UVB radiation, resveratrol can significantly inhibit the upregulation of cyclooxygenase-2 (COX-2) expression and subsequently reduce the levels of its downstream product prostaglandin E2 (PGE2) and pro-inflammatory cytokine interleukin-6 (IL-6)This suggests that it has potential applications in fields such as skin photoaging and inflammatory skin diseases. In animal inflammation models such as carrageenan induced toe swelling in rats and acetic acid induced increased intra-abdominal capillary permeability in mice, resveratrol also showed clear anti-inflammatory effects.
-
Cardiovascular protective activity This is one of the most promising research directions for resveratrol. Its cardiovascular protective effect is manifested as multi-target and multi pathway:
- Hypotensive effect In animal models such as spontaneously hypertensive rats (SHR), oral administration of resveratrol can dose dependently reduce arterial blood pressure. Its effect is mild and long-lasting.
- Vasodilatory effect In vitro vascular ring experiments have shown that resveratrol can dilate blood vessels pre contracted by norepinephrine, which is partially dependent on endothelial function and may be related to promoting the release of nitric oxide (NO).
- cardioprotection In the isoproterenol induced myocardial injury model, pre-treatment with resveratrol can alleviate pathological changes in myocardial tissue and reduce the levels of serum myocardial injury markers such as creatine kinase and lactate dehydrogenase. Its mechanism is related to antioxidant and anti apoptotic effects.
-
Other activities The study also suggests that resveratrol may have neuroprotective, anti-tumor proliferation, antibacterial and other activities, but research in these areas is still in the preliminary stage and requires more evidence to support it.
Mechanism of action and molecular targets
The multiple pharmacological activities of resveratrol stem from its regulation of cellular signaling pathways and interactions with multiple molecular targets. Its core mechanism revolves around antioxidant stress and anti-inflammatory effects, and acts on a series of key targets in the cardiovascular system.
-
Mechanisms related to anti-inflammatory and antioxidant effects：
- Inhibition of NF - κ B signaling pathway NF - κ B is a core transcription factor that regulates the expression of various inflammatory factors such as COX-2, IL-6, TNF - α, etc. Research has shown that resveratrol can inhibit the degradation of I κ B α, prevent the transfer of NF - κ B p65 subunit to the nucleus, and thus suppress the expression of downstream inflammatory genes at the transcriptional level. This is one of the main molecular mechanisms by which it reduces the levels of COX-2 and IL-6.
- MAPK signaling pathway regulation Stimulation with UVB or LPS can activate signaling pathways such as p38 MAPK, JNK, and ERK. Resveratrol has been shown to inhibit the excessive phosphorylation of these kinases, thereby suppressing the activity of transcription factors such as AP-1 and synergistically suppressing inflammatory responses.
- Nrf2/ARE pathway activation Nrf2 is the main regulator of cellular antioxidant response. There are studies suggesting that resveratrol may upregulate the expression of phase II detoxifying enzymes and antioxidant proteins such as heme oxygenase-1 (HO-1) and quinone oxidoreductase 1 (NQO1) by promoting Nrf2 nuclear translocation and activating antioxidant response elements (ARE), thereby enhancing the cell's own antioxidant defense ability.
-
Cardiovascular protection related targets and mechanisms：
The antihypertensive and cardiovascular protective effects of resveratrol involve comprehensive regulation of the renin angiotensin aldosterone system (RAAS), sympathetic nervous system, and endothelial function.
- Angiotensin converting enzyme (ACE)ACE is a key enzyme in the RAAS system, catalyzing the conversion of angiotensin I into the potent vasoconstrictor angiotensin II. Molecular docking and in vitro enzyme activity experiments suggest that resveratrol may act as a competitive inhibitor of ACE, reducing the production of angiotensin II and producing vasodilator and antihypertensive effects.
- Endothelial nitric oxide synthase (NOS3)Resveratrol may activate the PI3K/Akt signaling pathway, promote the phosphorylation and activation of NOS3 in endothelial cells, increase the production of NO with vasodilatory, anti-inflammatory, and anti proliferative effects, and improve endothelial function.
- Angiotensin II receptor type 1 (AGTR1)In addition to inhibiting ACE, resveratrol may also directly or indirectly antagonize the binding of angiotensin II to its main receptor AGTR1, blocking its pathological effects such as vasoconstriction, aldosterone release, and fibrosis.
- Adrenergic receptors (ADRB1, ADRA1)Resveratrol acid may have a regulatory effect on β 1-adrenergic receptors (ADRB1) and α 1-adrenergic receptors (ADRA1). The potential antagonistic effect of ADRB1 may help slow down heart rate and reduce myocardial oxygen consumption; The potential antagonistic effect of ADRA1 can directly lead to vascular smooth muscle relaxation and reduce peripheral resistance. These effects collectively contribute to its antihypertensive effect.
Evaluation of drug properties and pharmacokinetics
The pharmacological evaluation based on calculations and preliminary experimental data shows that resveratrol has great potential for development as an oral medication. Its molecular weight is small (<500), LogP is moderate (1.95), and TPSA is low (<60 Å ²), which meets the basic requirements of the Rule of Five for oral active compounds, indicating that it may have good oral absorption and bioavailability. The low permeability of the blood-brain barrier may reduce central side effects when targeting peripheral system diseases such as hypertension and arthritis. The absence of hERG inhibition and genetic toxicity warning laid the foundation for its preclinical safety assessment.
However, pharmacokinetic studies on the resveratrol system are currently relatively limited, with existing information mostly coming from animal experiments and in vitro models
* Absorption and distribution Resveratrol is rapidly absorbed in the gastrointestinal tract. Its moderate lipid solubility and smaller molecular size are conducive to passive diffusion absorption. Animal experiments have shown that the prototype drug and its metabolites can be detected quickly in plasma after oral administration.
* Metabolism As a phenolic acid compound, resveratrol mainly undergoes II combined metabolism Its benzoic acid structure may directly bind with glucuronic acid or sulfuric acid to form more water-soluble complexes. In addition, its methoxy group may be catalyzed by the liver cytochrome P450 enzyme system (such as CYP450)demethylation, converted into monomethoxy or catechol metabolites (such as isovanillic acid). These metabolites may still have biological activity, or even stronger activity, and their pharmacological contributions cannot be ignored.
* excretion Metabolites are mainly excreted through the kidneys with urine, and some may also be excreted through bile.
* Challenge and Optimization Although resveratrol itself has superior properties, its metabolism in the body may be rapid, resulting in a short half-life and requiring frequent administration. If it is developed into a drug in the future, it may need to be developed through Structural modification(such as preparing prodrugs, introducing specific functional groups to slow down metabolism) or New drug delivery system(such as sustained-release formulations and nanocarrier systems) to optimize their pharmacokinetic characteristics, prolong their duration of action, and improve targeting.
Clinical application prospects and prospects
Resveratrol, as a natural active molecule with a wide range of sources and good preliminary safety evaluation, has shown promising application prospects in multiple disease fields, but also faces many challenges.
-
Potential application directions：
- Cardiovascular disease adjuvant therapy/prevention As a candidate molecule with multi-target effects for blood pressure reduction, resveratrol is expected to be developed as Adjuvant therapy drugs or functional health foods for mild hypertension Its antioxidant and anti-inflammatory properties also have potential protective effects on atherosclerosis, myocardial ischemia-reperfusion injury, etc.
- External skin preparation Based on its clear anti UVB induced skin inflammation effect (inhibition of COX-2/PGE2/IL-6), resveratrol can be added as an active ingredient to Sunscreen, post sun repair products, and ointments for treating photodermatitis In the middle.
- Chronic inflammatory diseases Resveratrol can be explored as an anti-inflammatory supplement for chronic inflammatory states such as rheumatoid arthritis and inflammatory bowel disease.
- Food and health product additives By utilizing its antioxidant properties, it can be used as a natural preservative or health ingredient in the food and dietary supplement industry.
-
challenges faced：
- Intensity and selectivity of action Compared with existing potent synthetic drugs such as ACE inhibitor Captopril, the monomeric activity of resveratrol may be relatively mild, making it more suitable for early intervention or combination therapy.
- Research on the in-depth mechanism of system operation At present, the interaction between multiple targets (such as ADRB1, ADRA1) is mostly predicted or indirectly evidenced, and more direct binding experiments and gene knockout/knockdown techniques are needed to confirm it.
- Complete preclinical and clinical research data is missing Lack of comprehensive pharmacokinetic and toxicological (long-term toxicity, reproductive toxicity, etc.) research data that comply with new drug development standards, as well as final human clinical trial evidence.
- Intellectual Property and Development Strategy As a known natural product, it may be difficult to obtain compound patent protection on its own, and the focus of development should be on New medical applications, unique compound combinations, optimized formulation processes, or derivatives with better pharmacokinetic properties。
-
Future research directions：
- Carry out systematic development ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Study Clearly define its safety window.
- apply Chemical and biological methods(such as affinity fishing and proteomics) comprehensively identify its direct target protein network.
- conduct Reasonable structural optimization While retaining its multi-target advantage, it improves the efficacy and metabolic stability towards specific key targets.
- Explore its presence combination therapy The value of it, such as being used in combination with existing antihypertensive drugs to reduce dosage and minimize side effects.
- Promote from dietary supplement Human observational studies and initial clinical trials conducted from a perspective to accumulate preliminary human efficacy and safety data.
Conclusion
Resveratrol acid (3,4-dimethoxybenzoic acid), as a natural polyphenolic acid widely present in fruits and vegetables, has gradually demonstrated its enormous potential as a multifunctional bioactive molecule from a common plant component. Its pharmacological effects in antioxidant, anti-inflammatory, and especially cardiovascular protection have been increasingly supported by abundant experimental evidence. Its mechanism of action involves the inhibition of inflammatory signaling pathways such as NF - κ B and MAPK, as well as the regulation of multiple cardiovascular key targets such as ACE, NOS3, and adrenergic receptors, reflecting the synergistic effect of natural products on multiple targets and pathways. The preliminary pharmacological prediction analysis also provides an optimistic physical, chemical, and safety basis for its transformation towards drug direction. However, to truly transform it into clinically usable drugs or high-value health products, it still requires a complete research and development chain that spans from in-depth explanation of the mechanism of action, pharmacokinetic system evaluation to rigorous human clinical trials. Future research should focus on addressing key issues such as activity intensity, metabolic stability, and target selectivity. In summary, the study of resveratrol not only provides a scientific annotation for understanding the concept of "food medicine homology", but also offers a promising lead compound for the development of new cardiovascular protective and anti-inflammatory drugs. Its subsequent development deserves continuous attention and investment in the fields of natural product pharmacology and medicinal chemistry.
